Skip to main content
SpringerLink
Log in

Hyperbaric Oxygen for Carbon Monoxide Poisoning

A Systematic Review and Critical Analysis of the Evidence

  • Review Article
  • Published:
Toxicological Reviews

Abstract

Poisoning with carbon monoxide (CO) is an important cause of unintentional and intentional injury worldwide. Hyperbaric oxygen (HBO) enhances CO elimination and has been postulated to reduce the incidence of neurological sequelae. These observations have led some clinicians to use HBO for selected patients with CO poisoning, although there is considerable variability in clinical practice.

This article assesses the effectiveness of HBO compared with normobaric oxygen (NBO) for the prevention of neurological sequelae in patients with acute CO poisoning. The following databases were searched: MEDLINE (1966 to present), EMBASE (1980 to present), and the Controlled Trials Register of the Cochrane Collaboration, supplemented by a manual review of bibliographies of identified articles and discussion with recognised content experts.

All randomised controlled trials involving people acutely poisoned with CO, regardless of severity, were examined. The primary analysis included all trials from which data could be extracted. Sensitivity analysis examined trials with better validity (defined using the validated instrument of Jadad) and those enrolling more severely poisoned patients.

Two reviewers independently extracted from each trial, including information on the number of randomised patients, types of participants, the dose and duration of the intervention, and the prevalence of neurological sequelae at follow-up. A pooled odds ratio (OR) for the presence of neurological symptoms at 1-month follow-up was calculated using a random effects model. Bayesian models were also investigated to illustrate the degree of certainty about clinical effectiveness.

Eight randomised controlled trials were identified. Two had no evaluable data and were excluded. The remaining trials were of varying quality and two have been published only as abstracts. The severity of CO poisoning varied among trials. At 1-month follow-up after treatment, sequelae possibly related to CO poisoning were present in 242 of 761 patients (36.1%) treated with NBO, compared with 259 of 718 patients (31.8%) treated with HBO. Restricting the analysis to the trials with the highest quality scores or those that enrolled all patients regardless of severity did not change the lack of statistical significance in the outcome of the pooled analysis. We found empiric evidence of multiple biases that operated to inflate the benefit of HBO in two positive trials. In contrast, the interpretation of negative trials was hampered by low rates of follow-up, unusual interventions for control patients and inclusion of less severely poisoned patients. Collectively, these limitations may have led negative trials to overlook a real and substantial benefit of HBO (type II error).

There is conflicting evidence regarding the efficacy of HBO treatment for patients with CO poisoning. Methodological shortcomings are evident in all published trials, with empiric evidence of bias in some, particularly those that suggest a benefit of HBO. Bayesian analysis further illustrates the uncertainty about a meaningful clinical benefit. Consequently, firm guidelines regarding the use of HBO for patients with CO poisoning cannot be established. Further research is needed to better define the role of HBO, if any, in the treatment of CO poisoning. Such research should not exclude patients with severe poisoning, have a primary outcome that is clinically meaningful and have oversight from an independent data monitoring and ethics committee.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I.
Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.

Similar content being viewed by others

References

  1. Weaver LK. Carbon monoxide poisoning. Crit Care Clin 1999; 15(2): 297–317

    Article  PubMed  CAS  Google Scholar 

  2. Hampson NB. Emergency department visits for carbon monoxide poisoning in the Pacific Northwest. J Emerg Med 1998; 16(5): 695–8

    Article  PubMed  CAS  Google Scholar 

  3. Seger D, Welch L. Carbon monoxide controversies: neuropsychologic testing, mechanism of toxicity, and hyperbaric oxygen. Ann Emerg Med 1994; 24(2): 242–8

    Article  PubMed  CAS  Google Scholar 

  4. Mathieu D, Nolf M, Durocher A, et al. Acute carbon monoxide poisoning: risk of late sequelae and treatment by hyperbaric oxygen. J Toxicol Clin Toxicol 1985; 23(4–6): 315–24

    Article  PubMed  CAS  Google Scholar 

  5. Norkool DM, Kirkpatrick JN. Treatment of acute carbon monoxide poisoning with hyperbaric oxygen: a review of 115 cases. Ann Emerg Med 1985; 14(12): 1168–71

    Article  PubMed  CAS  Google Scholar 

  6. Thom SR, Keim LW. Carbon monoxide poisoning: a review epidemiology, pathophysiology, clinical findings, and treatment options including hyperbaric oxygen therapy. J Toxicol Clin Toxicol 1989; 27(3): 141–56

    Article  PubMed  CAS  Google Scholar 

  7. Mitton C, Hailey D. Health technology assessment and policy decisions on hyperbaric oxygen treatment. Int J Technol Assess Health Care 1999; 15(4): 661–70

    PubMed  CAS  Google Scholar 

  8. Juurlink DN, Stanbrook MB, McGuigan MA. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev 2000; (2): CD002041

    Google Scholar 

  9. Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 2002; 347(14): 1057–67

    Article  PubMed  CAS  Google Scholar 

  10. Raphael JC, Chevret S, Driheme A, et al. Managing carbon monoxide poisoning with hyperbaric oxygen. Proceedings of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT); 2004 Jun 3; Strasbourg, 49–50

  11. Hampson NB, Dunford RG, Ross DE, et al. A prospective, randomized clinical trial comparing two hyperbaric treatment protocols for carbon monoxide poisoning. Undersea Hyperbaric Medicine Society Annual Scientific Meeting; 2004 May 29; Sydney

  12. Raphael JC, Elkharrat D, Jars GM, et al. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989; II: 414–9

    Article  Google Scholar 

  13. Scheinkestel CD, Bailey M, Myles PS, et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Med J Aust 1999; 170(5): 203–10

    PubMed  CAS  Google Scholar 

  14. Thom SR, Taber RL, Mendiguren II, et al. Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann Emerg Med 1995; 25(4): 474–80

    Article  PubMed  CAS  Google Scholar 

  15. Mathieu D, Wattel F, Mathieu-Nolf M, et al. Randomized prospective study comparing the effect of HBO vs. 12 hours NBO in non-comatose CO-poisoned patients: results of preliminary analysis. Undersea Hyperb Med 1996; 23 Suppl.: 7–8

    Google Scholar 

  16. Scheinkestel CD, Jones K, Cooper DJ, et al. Interim analysis: controlled clinical trial of hyperbaric oxygen in acute carbon monoxide (CO) poisoning. Undersea Hyperb Med 1996; 23 Suppl.: 7

    Google Scholar 

  17. Thom SR, Taber RL, Mendiguren II, et al. Delayed neuropsychologic sequelae following CO poisoning and the role of treatment with 100% O2 or hyperbaric oxygen: a prospective randomized, clinical study. Undersea Biomed Res 1992; 19 Suppl.: 47

    Google Scholar 

  18. Weaver LK, Hopkins RO, Larson-Lohr V, et al. Double blind, controlled, prospective, randomized clinical trial (RCT) in patients with acute carbon monoxide (CO) poisoning: outcome of patients treated with normobaric oxygen or hyperbaric oxygen (HBO): an interim report. Undersea Hyperb Med 1995; 22 Suppl.: 14

    Google Scholar 

  19. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17(1): 1–12

    Article  PubMed  CAS  Google Scholar 

  20. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273(5): 408–12

    Article  PubMed  CAS  Google Scholar 

  21. Ducasse JL, Celsis P, Marc-Vergnes JP. Non-comatose patients with acute carbon monoxide poisoning: hyperbaric or normobaric oxygenation? Undersea Hyperb Med 1995; 22(1): 9–15

    PubMed  CAS  Google Scholar 

  22. Schulz KF. Subverting randomization in controlled trials. JAMA 1995; 274: 1456–8

    Article  PubMed  CAS  Google Scholar 

  23. Weaver LK, Hopkins RO, Chan KJ, et al. Carbon Monoxide Research Group, LDS Hospital, Utah in reply to Scheinkestel et al. and Emerson: the role of hyperbaric oxygen in carbon monoxide poisoning. Emerg Med Australas 2004; 16(5–6): 394–9

    Article  PubMed  Google Scholar 

  24. Juurlink D, Buckley N, Stanbrook M, et al. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev 2005; (1): CD002041

    Google Scholar 

  25. Letzel H. ‘Best-evidence synthesis: an intelligent alternative to meta-analysis’: discussion: a case of ‘either-or’ or ‘as well’. J Clin Epidemiol 1995; 48(1): 19–21

    Article  PubMed  CAS  Google Scholar 

  26. Hampson NB, Mathieu D, Piantadosi CA, et al. Carbon monoxide poisoning: interpretation of randomized clinical trials and unresolved treatment issues. Undersea Hyperb Med 2001; 28(3): 157–64

    PubMed  CAS  Google Scholar 

  27. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134(8): 663–94

    PubMed  CAS  Google Scholar 

  28. Puffer S, Torgerson D, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ 2003; 327(7418): 785–9

    Article  PubMed  Google Scholar 

  29. Scheinkestel CD, Tuxen DV, Bailey M, et al. Hyperbaric oxygen in carbon monoxide poisoning: authors of study clarify points that they made [letter]. BMJ 2000; 321(7253): 109–10

    Article  PubMed  CAS  Google Scholar 

  30. Weaver LK. Hyperbaric oxygen in carbon monoxide poisoning. BMJ 1999; 319(7217): 1083–4

    Article  PubMed  CAS  Google Scholar 

  31. Moon RE, DeLong E. Hyperbaric oxygen for carbon monoxide poisoning. Med J Aust 1999; 170(5): 197–9

    PubMed  CAS  Google Scholar 

  32. Chan AW, Hrobjartsson A, Haahr MT, et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004; 291(20): 2457–65

    Article  PubMed  CAS  Google Scholar 

  33. Kaptchuk TJ. Effect of interpretive bias on research evidence. BMJ 2003; 326(7404): 1453–5

    Article  PubMed  Google Scholar 

  34. Juni P, Rutjes AW, Dieppe PA. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs? BMJ 2002; 324(7349): 1287–8

    Article  PubMed  Google Scholar 

  35. Freemantle N. Interpreting the results of secondary endpoints and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? BMJ 2001; 322: 989–91

    Article  PubMed  CAS  Google Scholar 

  36. Sleight P. Debate: subgroup analyses in clinical trials: fun to look at — but don’t believe them! Curr Control Trials Cardiovasc Med 2000; 1(1): 25–7

    Article  PubMed  Google Scholar 

  37. Weaver LK, Hopkins RO, Larson-Lohr V. Hyperbaric oxygen and carbon monoxide poisoning. Ann Emerg Med 1995; 26(3): 390–2

    PubMed  CAS  Google Scholar 

  38. Weaver LK, Hopkins RO, Larson-Lohr V. Carbon monoxide poisoning: a review of human outcome studies comparing normobaric oxygen with hyperbaric oxygen. Ann Emerg Med 1995; 25(2): 271–2

    Article  PubMed  CAS  Google Scholar 

  39. DeAngelis CD, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the international committee of medical journal editors. JAMA 2004; 292(11): 1363–4

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Parts of this review have been published as a Cochrane review (see Juurlink et al.[[24]]). David Juurlink is supported by a New Investigator Award from the Canadian Institutes of Health Research, and by the University of Toronto Drug Safety Research Group. Geoffrey Isbister is supported by an NHMRC Clinical Career Development Award ID300785. The authors have no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology and Toxicology, Australian National University Medical School, Canberra, Australian Capital Territory, Australia

    Nicholas A. Buckley

  2. Emergency Department, Newcastle Mater Hospital, Newcastle, New South Wales, Australia

    Geoffrey K. Isbister

  3. Discipline of Clinical Pharmacology, University of Newcastle, Newcastle, New South Wales, Australia

    Geoffrey K. Isbister & Barrie Stokes

  4. Departments of Medicine, Pediatrics, and Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada

    David N. Juurlink

Authors
  1. Nicholas A. Buckley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geoffrey K. Isbister
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barrie Stokes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David N. Juurlink
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicholas A. Buckley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buckley, N.A., Isbister, G.K., Stokes, B. et al. Hyperbaric Oxygen for Carbon Monoxide Poisoning. Toxicol Rev 24, 75–92 (2005). https://doi.org/10.2165/00139709-200524020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00139709-200524020-00002

Keywords

Search

Navigation